Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT

Current Issue

Year 2020

Volume: 7 , Issue: 2

Article Access statistics

Viewed: 592

Emailed: 0

PDF Downloaded: 210

Indian Journal of Clinical Anaesthesia


Comparison between palonosetron and ramosetron to prevent postoperative nausea and vomiting in patients undergoing laparoscopic surgery


Full Text PDF Share on Facebook Share on Twitter


Author Details : Patel Vaibhavi B*, Patel Kiran B, Mehta Vikram P, Agarwal Sameermohan, Patel Hardik G

Volume : 5, Issue : 3, Year : 2018

Article Page : 348-353


Suggest article by email

Abstract

Introduction and Aims: Postoperative nausea and vomiting (PONV) are very common and distressing adverse events after general anaesthesia. Palonosetron and ramosetron are newer, second generation, selective 5-HT3 receptor antagonists. The present study was carried out to compare the efficacy and safety of palonosetron and ramosetron for prevention of postoperative nausea and vomiting (PONV) over the period of 72 hours in patients undergoing for laparoscopic surgery under general anaesthesia.
Materials and Methods: 80 patients of ASA class I and II undergoing for various laparoscopic surgeries were randomly allocated into 2 groups of 40 each, to receive Inj. palonosetron 75 ?g (group P) or Inj. Ramosetron 0.3 mg (group R). Patients were monitored for emesis, severity of nausea, requirement of rescue antiemetic and complete response up to 72 hours (0-6, 6-24, 24-72) post operatively.
Results: During 0-6 hours, severity of PONV was comparable in both drug groups but during 24-72 hours, PONV score 2 was observed in 5% and 17.5% of patients of group P and group R respectively (p=0.027). While score 3 was observed in 15% of patients of group R and none of the patients of group P (p=0.01). On comparison of complete response between Group P and Group R, at 0-6 hours response was almost equal but during 6-24 hours and 24-72 hours number of patient having complete response were more in Group P (97.5% and 82.5%) as compared to Group R (65% and 57% respectively).
Conclusion: Palonosetron given as a prophylaxis for post-operative nausea and vomiting (PONV) in patients undergoing for laparoscopic surgeries seems to have better antiemetic effect over ramosetron.

Keywords: PONV, Palonosetron, Ramosetron, Laparoscopic surgery.

Doi : 10.18231/2394-4994.2018.0066

How to cite : Patel Vaibhavi B, Patel Kiran B, Mehta Vikram P, Sameermohan A, Patel Hardik G, Comparison between palonosetron and ramosetron to prevent postoperative nausea and vomiting in patients undergoing laparoscopic surgery. Indian J Clin Anaesth 2018;5(3):348-353

Copyright © 2018 by author(s) and Indian J Clin Anaesth. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)